Thiazides and related diuretics, their current position and role in the treatment of arterial hypertension
https://doi.org/10.51523/2708-6011.2009-6-4-15
Abstract
About the Authors
G. M. BronskayaBelarus
T. A. Korshak
Belarus
D. V. Kazakevich
Belarus
References
1. Collins, R. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context / R. Collins // Lancet. 1990. - Vol. 335. - P. 827-838.
2. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: The Cardiovascular Health Study / B. Psaty [et al.] // Arch Intern Med. - 2002. - Vol. 162. - P. 2325-2332.
3. Kaplan, T. L. Clinical Hypertension / T. L. Kaplan. - Philadelphia. Lippricont, 2002.
4. Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report / A. V. Chobanian [et al.] // JAMA. - 2003. - Vol. 289. - P. 2560-2572.
5. Некоторые данные по фармакоэпидемиологии диуретиков в лечении артериальной гипертензии / В. П. Вдовиченко [и др.] // Журнал ГГМУ. - 2006. - № 4. - С. 60-63.
6. Анализ врачебных предпочтений при амбулаторном лечении артериальной гипертензии / В. П. Вдовиченко [и др.] // Журнал ГГМУ. - 2006. - № 4. - С. 55-59.
7. Pathophysiology of antihypertensive therapy with diuretics / M. Fukuda [et al.] // Hypertens Res. - 2006. - Vol. 29(9). - P. 645-653.
8. Katzung, B. Basic and clinical pharmacology / B. Katzung. - Lange Medical Books. - 2004. - P. 160-183, 241-258.
9. Thiazide diuretics in the treatment of hypertension: an update / A. Salvetti [et al] // J Am Soc Nephrol. - 2006. - Vol. 4. - Suppl. 2. - P. 25-29.
10. Tuck, M. L. Metabolic considerations in hypertension / M. L. Tuck // Am J Hypertens. - 1990. - Vol. 3. - P. 355-365.
11. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) / ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group // JAMA. - 2002. - Vol. 288. - P. 2981-2997.
12. High and low serum potassium associated with cardiovascular events in diuretic-treated patients / H. W. Cohen [et al.] // J Hypertens. - Vol. 19. - P. 1315-1323.
13. Mancia, G. The task force for the management of arterial hypertension of the European Society of Hypertension, 2007 Guidelines for the management of arterial hypertension / G. Mancia // Eur Heart J. - 2007. - Vol. 12. - P. 1462-1536.
14. Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies / Psaty [et al.] // JAMA. - 2004. - Vol. 292. - P. 43-44.
15. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis / Psaty [et al.] // JAMA. - 2004. - Vol. 277. - P. 739-745.
16. Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability / B. L. Carter [et al.] // Hypertension. - 2004. - Vol. 43. - P. 4-9.
17. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose / B. J. Materson [et al.] // Clin Pharmacol Ther. - 1978. - Vol. 24. - P.192-198.
Review
For citations:
Bronskaya G.M., Korshak T.A., Kazakevich D.V. Thiazides and related diuretics, their current position and role in the treatment of arterial hypertension. Health and Ecology Issues. 2009;(4):74-79. (In Russ.) https://doi.org/10.51523/2708-6011.2009-6-4-15